PRAZIQUANTEL

PRAZIQUANTEL was reported 303 times

PRAZIQUANTEL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MAZZOTTI REACTION 2 0.1818
1 SCHISTOSOMIASIS 11 0.1429
2 CEREBRAL PARENCHYMAL CALCIFICATION 1 0.1429
3 PARASITIC ENCEPHALITIS 1 0.1111
4 HYMENOLEPIASIS 1 0.1111
5 SUBCONJUNCTIVAL FIBROSIS 1 0.0909
6 ANGIOGRAM PERIPHERAL ABNORMAL 1 0.0769
7 TAENIASIS 3 0.0714
8 NEUROCYSTICERCOSIS 3 0.0667
9 HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS 1 0.0588
10 NECK CRUSHING 1 0.0500
11 HEPATITIS B DNA ASSAY POSITIVE 5 0.0391
12 PROGRESSIVE MUSCULAR ATROPHY 1 0.0323
13 PORTAL VEIN CAVERNOUS TRANSFORMATION 1 0.0244
14 TONGUE ATROPHY 1 0.0204
15 ARTERIAL STENOSIS LIMB 1 0.0196
16 PLAGUE 1 0.0149
17 RED BLOOD CELL SCHISTOCYTES PRESENT 4 0.0123
18 SALMONELLA TEST POSITIVE 1 0.0116
19 CEREBRAL MASS EFFECT 4 0.0110
20 THERAPEUTIC RESPONSE PROLONGED 1 0.0106
21 ECZEMA INFANTILE 1 0.0104
22 MULTIPLE DRUG HYPERSENSITIVITY 1 0.0104
23 VULVA CYST 1 0.0095
24 PORTAL FIBROSIS 2 0.0093
25 EXTRAOCULAR MUSCLE DISORDER 3 0.0093
26 CNS VENTRICULITIS 3 0.0092
27 HABITUAL ABORTION 1 0.0088
28 GASTRIC PH INCREASED 1 0.0087
29 EYELASH THICKENING 1 0.0083
30 PLASMODIUM FALCIPARUM INFECTION 1 0.0081
31 SPLINTER HAEMORRHAGES 1 0.0073
32 VASCULITIS CEREBRAL 3 0.0067
33 BILIARY FISTULA 1 0.0065
34 CERVIX CANCER METASTATIC 1 0.0061
35 CYST RUPTURE 4 0.0059
36 VESSEL PUNCTURE SITE HAEMATOMA 1 0.0051
37 BIRTH MARK 1 0.0048
38 PARALYSIS FLACCID 1 0.0046
39 OPTIC DISC HAEMORRHAGE 1 0.0044
40 HELMINTHIC INFECTION 1 0.0041
41 SUPERFICIAL VEIN PROMINENCE 1 0.0039
42 SYMBLEPHARON 1 0.0038
43 SPINAL MUSCULAR ATROPHY 1 0.0037
44 SUDDEN VISUAL LOSS 1 0.0036
45 SHUNT MALFUNCTION 1 0.0035
46 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
47 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
48 CEREBRAL CYST 2 0.0029
49 PTERYGIUM 1 0.0029
50 ORAL DISCHARGE 1 0.0027
51 LIPID METABOLISM DISORDER 1 0.0026
52 ARACHNOID CYST 1 0.0025
53 POLYSEROSITIS 1 0.0023
54 DIVORCED 1 0.0023
55 HOMELESS 1 0.0022
56 VEIN DISCOLOURATION 1 0.0021
57 STEROID DIABETES 3 0.0020
58 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
59 HYPEREOSINOPHILIC SYNDROME 1 0.0018
60 NAIL BED BLEEDING 1 0.0018
61 INTENTION TREMOR 1 0.0018
62 CONJUNCTIVAL HYPERAEMIA 6 0.0017
63 SINOATRIAL BLOCK 1 0.0017
64 GRUNTING 1 0.0017
65 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
66 PERIORAL DERMATITIS 1 0.0016
67 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
68 HYPERCHLORAEMIA 1 0.0016
69 RESTING TREMOR 1 0.0015
70 SPUTUM PURULENT 1 0.0015
71 PERSONAL RELATIONSHIP ISSUE 1 0.0015
72 JARISCH-HERXHEIMER REACTION 1 0.0014
73 PALMOPLANTAR KERATODERMA 1 0.0014
74 TRAUMATIC FRACTURE 1 0.0014
75 LIMB CRUSHING INJURY 1 0.0013
76 ANOSOGNOSIA 1 0.0013
77 HYDROCEPHALUS 7 0.0013
78 MYOPERICARDITIS 1 0.0013
79 INFECTION PARASITIC 1 0.0013
80 GALLBLADDER POLYP 1 0.0013
81 SUPERINFECTION BACTERIAL 1 0.0013
82 STRONGYLOIDIASIS 2 0.0012
83 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
84 HEPATORENAL SYNDROME 2 0.0012
85 VITREOUS OPACITIES 1 0.0012
86 LIP PRURITUS 1 0.0012
87 FOOD INTERACTION 2 0.0011
88 EXTENSOR PLANTAR RESPONSE 1 0.0011
89 RETINAL EXUDATES 1 0.0011
90 ANTISOCIAL BEHAVIOUR 1 0.0010
91 PORTAL HYPERTENSION 3 0.0010
92 RETINAL TOXICITY 1 0.0010
93 NASAL INFLAMMATION 1 0.0009
94 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
95 COMPLEX PARTIAL SEIZURES 1 0.0009
96 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
97 APPLICATION SITE DISCHARGE 1 0.0009
98 NEUROLOGICAL DECOMPENSATION 2 0.0009
99 PENILE SWELLING 1 0.0008
100 NOCTURNAL DYSPNOEA 1 0.0008
101 FEELING GUILTY 1 0.0008
102 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
103 ANGIONEUROTIC OEDEMA 2 0.0007
104 EOSINOPHILIA 13 0.0007
105 URETERIC OBSTRUCTION 1 0.0007
106 EFFUSION 1 0.0007
107 MENINGITIS BACTERIAL 1 0.0007
108 ACNE CYSTIC 2 0.0007
109 CUSHINGOID 2 0.0006
110 PORTAL VEIN THROMBOSIS 2 0.0006
111 OPTIC ATROPHY 1 0.0006
112 SEBORRHOEIC DERMATITIS 1 0.0006
113 ARTHROPOD STING 1 0.0006
114 TONGUE COATED 1 0.0006
115 PRODUCT PRESCRIBING ISSUE 12 0.0006
116 RETINOPATHY 2 0.0005
117 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
118 CLEFT PALATE 1 0.0005
119 CONVERSION DISORDER 1 0.0005
120 PERIPHERAL ISCHAEMIA 2 0.0005
121 LIVEDO RETICULARIS 1 0.0005
122 LATENT TUBERCULOSIS 1 0.0005
123 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
124 OCULAR ICTERUS 2 0.0005
125 LARGE INTESTINAL OBSTRUCTION 1 0.0004
126 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
127 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
128 HYPERTRANSAMINASAEMIA 3 0.0004
129 EYELID OEDEMA 5 0.0004
130 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
131 ABDOMINAL TENDERNESS 2 0.0004
132 HYPERNATRAEMIA 2 0.0004
133 VASODILATATION 1 0.0004
134 URINARY TRACT INFECTION BACTERIAL 1 0.0004
135 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
136 HEPATOSPLENOMEGALY 1 0.0004
137 RETINAL DISORDER 1 0.0004
138 HEPATITIS TOXIC 1 0.0004
139 ALCOHOL ABUSE 1 0.0004
140 GAMBLING DISORDER 1 0.0004
141 SKIN WRINKLING 1 0.0004
142 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
143 EOSINOPHIL COUNT INCREASED 3 0.0004
144 PHARYNGEAL DISORDER 1 0.0003
145 PARAPLEGIA 1 0.0003
146 HEPATITIS FULMINANT 1 0.0003
147 CREPITATIONS 1 0.0003
148 CHOLECYSTITIS 4 0.0003
149 MIXED LIVER INJURY 1 0.0003
150 LOSS OF EMPLOYMENT 1 0.0003
151 VARICES OESOPHAGEAL 1 0.0003
152 PATHOGEN RESISTANCE 3 0.0003
153 DERMATITIS ACNEIFORM 2 0.0003
154 PENILE PAIN 1 0.0003
155 DUODENITIS 1 0.0003
156 CYST 4 0.0003
157 SWOLLEN JOINT COUNT INCREASED 1 0.0003
158 CYTOLYTIC HEPATITIS 1 0.0003
159 LYME DISEASE 1 0.0003
160 HEPATIC CYST 1 0.0003
161 TACHYPHRENIA 1 0.0003
162 HYPERREFLEXIA 1 0.0003
163 FOLLICULITIS 3 0.0003
164 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
165 OSTEONECROSIS 9 0.0003
166 PROTEIN TOTAL DECREASED 1 0.0003
167 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
168 POLYDIPSIA 1 0.0003
169 RHINITIS 2 0.0002
170 FUNGAL SKIN INFECTION 1 0.0002
171 HOMICIDAL IDEATION 1 0.0002
172 SHOCK HAEMORRHAGIC 2 0.0002
173 ABNORMAL FAECES 2 0.0002
174 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
175 BRAIN OEDEMA 3 0.0002
176 HEPATIC CYTOLYSIS 3 0.0002
177 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
178 CARDIAC FAILURE CHRONIC 1 0.0002
179 HEPATITIS 6 0.0002
180 MELANOCYTIC NAEVUS 1 0.0002
181 RHEUMATIC FEVER 1 0.0002
182 PAPILLOEDEMA 1 0.0002
183 SUSPECTED OFF LABEL USE 1 0.0002
184 ACUTE HEPATIC FAILURE 3 0.0002
185 HEPATOCELLULAR INJURY 3 0.0002
186 FAECAL INCONTINENCE 1 0.0002
187 STILLBIRTH 1 0.0002
188 HYPERVOLAEMIA 1 0.0002
189 VULVOVAGINAL PRURITUS 1 0.0002
190 NEUTROPHIL COUNT INCREASED 2 0.0002
191 VARICOSE VEIN 1 0.0002
192 FOETAL DEATH 1 0.0002
193 APLASTIC ANAEMIA 1 0.0002
194 SERUM FERRITIN INCREASED 1 0.0002
195 ANORECTAL DISCOMFORT 1 0.0002
196 ABSCESS 3 0.0002
197 MALNUTRITION 2 0.0002
198 MACULAR OEDEMA 1 0.0002
199 REBOUND EFFECT 2 0.0002
200 CHOLECYSTITIS ACUTE 1 0.0002
201 GENERALISED ERYTHEMA 1 0.0002
202 VISUAL DISTURBANCE 1 0.0002
203 RHEUMATOID FACTOR POSITIVE 1 0.0002
204 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
205 SPLENOMEGALY 2 0.0002
206 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
207 SYMPTOM RECURRENCE 1 0.0002
208 ENDOPHTHALMITIS 1 0.0002
209 PIGMENTATION DISORDER 1 0.0002
210 OLIGURIA 1 0.0002
211 CHOLESTASIS 3 0.0002
212 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
213 INCOHERENT 1 0.0002
214 HEPATITIS ACUTE 1 0.0002
215 IMMUNE SYSTEM DISORDER 2 0.0002
216 HYPOKALAEMIA 7 0.0002
217 CARDIAC FAILURE ACUTE 1 0.0001
218 FORMICATION 1 0.0001
219 PANCYTOPENIA 8 0.0001
220 PRODUCT SUPPLY ISSUE 1 0.0001
221 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
222 RASH PUSTULAR 1 0.0001
223 HYPOPHOSPHATAEMIA 1 0.0001
224 ARTHROPOD BITE 1 0.0001
225 HEPATOTOXICITY 3 0.0001
226 DUODENAL ULCER PERFORATION 1 0.0001
227 THERAPY PARTIAL RESPONDER 2 0.0001
228 DRUG-INDUCED LIVER INJURY 4 0.0001
229 NASAL DISCOMFORT 1 0.0001
230 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
231 SENSORY LOSS 1 0.0001
232 HYPERAESTHESIA 1 0.0001
233 ESCHERICHIA INFECTION 1 0.0001
234 PHOTOSENSITIVITY REACTION 2 0.0001
235 LIVE BIRTH 1 0.0001
236 SKIN HYPERPIGMENTATION 1 0.0001
237 UNRESPONSIVE TO STIMULI 3 0.0001
238 MYOPATHY 1 0.0001
239 LIVER DISORDER 5 0.0001
240 RESPIRATORY RATE INCREASED 1 0.0001
241 SEIZURE 13 0.0001
242 MYELOSUPPRESSION 4 0.0001
243 OROPHARYNGEAL DISCOMFORT 1 0.0001
244 OPTIC NEURITIS 1 0.0001
245 UROSEPSIS 1 0.0001
246 CONJUNCTIVITIS 2 0.0001
247 SQUAMOUS CELL CARCINOMA 1 0.0001
248 HEPATOMEGALY 1 0.0001
249 HYPOTONIA 1 0.0001
250 SALIVARY HYPERSECRETION 1 0.0001
251 VAGINAL DISCHARGE 1 0.0001
252 HELICOBACTER INFECTION 1 0.0001
253 FAECES DISCOLOURED 2 0.0001
254 ANGIOEDEMA 4 0.0001
255 TRANSAMINASES INCREASED 2 0.0001
256 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
257 CHROMATURIA 2 0.0001
258 STATUS EPILEPTICUS 1 0.0001
259 SCAB 1 0.0001
260 CHOLECYSTECTOMY 1 0.0001
261 SEXUAL DYSFUNCTION 1 0.0001
262 DISEASE RECURRENCE 4 0.0001
263 CEREBRAL INFARCTION 2 0.0001
264 ENCEPHALOPATHY 2 0.0001
265 GENERALISED OEDEMA 1 0.0001
266 HAIR COLOUR CHANGES 1 0.0001
267 PEMPHIGUS 1 0.0001
268 MUSCLE ATROPHY 1 0.0001
269 ANAPHYLACTIC SHOCK 2 0.0001
270 RASH GENERALISED 2 0.0001
271 HAND DEFORMITY 1 0.0001
272 BEDRIDDEN 1 0.0001
273 ORAL CANDIDIASIS 1 0.0001
274 BLOOD BILIRUBIN INCREASED 2 0.0001
275 OEDEMA 4 0.0001
276 PNEUMONITIS 2 0.0001
277 SKIN LESION 2 0.0001
278 RESPIRATORY DISTRESS 2 0.0001
279 TREATMENT FAILURE 6 0.0001
280 HYPOMAGNESAEMIA 1 0.0001
281 COORDINATION ABNORMAL 1 0.0001
282 APHONIA 1 0.0001
283 EYE PAIN 4 0.0001
284 SINUS TACHYCARDIA 1 0.0001
285 BRONCHOSPASM 1 0.0001
286 ANGINA PECTORIS 2 0.0001
287 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
288 ASCITES 2 0.0001
289 ECONOMIC PROBLEM 1 0.0001
290 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
291 NERVOUS SYSTEM DISORDER 2 0.0001
292 CYANOSIS 1 0.0001
293 PYREXIA 22 0.0001
294 ARRHYTHMIA 3 0.0001
295 SCIATICA 1 0.0001
296 MANIA 1 0.0001
297 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
298 LEUKOPENIA 3 0.0001
299 SKIN DISORDER 2 0.0001
300 URTICARIA 10 0.0001
301 PERICARDITIS 1 0.0001
302 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
303 HEPATIC ENZYME INCREASED 4 0.0001
304 SCAR 1 0.0001
305 MUSCULOSKELETAL DISCOMFORT 1 0.0001
306 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
307 LYMPHADENOPATHY 2 0.0001
308 DRUG ERUPTION 1 0.0001
309 THIRST 1 0.0001
310 SYNOVITIS 1 0.0001
311 LEUKOCYTOSIS 1 0.0001
312 TREATMENT NONCOMPLIANCE 3 0.0001
313 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
314 AGRANULOCYTOSIS 1 0.0001
315 HEPATIC CIRRHOSIS 1 0.0001
316 BLOOD SODIUM DECREASED 1 0.0001
317 CONDITION AGGRAVATED 16 0.0001
318 ACUTE KIDNEY INJURY 8 0.0001
319 ACUTE RESPIRATORY FAILURE 1 0.0001
320 SKIN FISSURES 1 0.0001
321 DISORIENTATION 2 0.0001
322 ABORTION SPONTANEOUS 2 0.0000
323 BODY TEMPERATURE INCREASED 1 0.0000
324 PERITONITIS 1 0.0000
325 IMPAIRED WORK ABILITY 1 0.0000
326 PRURITUS GENERALISED 1 0.0000
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
328 STEVENS-JOHNSON SYNDROME 1 0.0000
329 RASH MACULO-PAPULAR 1 0.0000
330 GLOSSODYNIA 1 0.0000
331 NEPHROLITHIASIS 2 0.0000
332 MUSCLE TWITCHING 1 0.0000
333 RASH ERYTHEMATOUS 2 0.0000
334 LOCALISED INFECTION 1 0.0000
335 MENTAL IMPAIRMENT 1 0.0000
336 FIBROMYALGIA 1 0.0000
337 UNDERDOSE 3 0.0000
338 LIVER INJURY 1 0.0000
339 PNEUMONIA ASPIRATION 1 0.0000
340 OFF LABEL USE 35 0.0000
341 ABDOMINAL PAIN LOWER 1 0.0000
342 HAEMATEMESIS 1 0.0000
343 CARDIOVASCULAR DISORDER 1 0.0000
344 ABDOMINAL PAIN 9 0.0000
345 ABDOMINAL DISTENSION 4 0.0000
346 SEDATION 1 0.0000
347 SPEECH DISORDER 2 0.0000
348 ANHEDONIA 1 0.0000
349 PANCREATITIS 2 0.0000
350 DRUG INTERACTION 6 0.0000
351 JAUNDICE 1 0.0000
352 NEUTROPENIA 5 0.0000
353 PALLOR 1 0.0000
354 ANAPHYLACTIC REACTION 2 0.0000
355 PROCEDURAL PAIN 1 0.0000
356 MENTAL STATUS CHANGES 1 0.0000
357 SEPSIS 4 0.0000
358 HAEMOPTYSIS 1 0.0000
359 WOUND 1 0.0000
360 SKIN EXFOLIATION 3 0.0000
361 RED BLOOD CELL COUNT DECREASED 1 0.0000
362 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
363 ABDOMINAL PAIN UPPER 7 0.0000
364 WHEEZING 2 0.0000
365 RESPIRATORY DISORDER 1 0.0000
366 PREMATURE BABY 1 0.0000
367 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
368 SUICIDE ATTEMPT 2 0.0000
369 OEDEMA PERIPHERAL 4 0.0000
370 HYPERSENSITIVITY 6 0.0000
371 VOMITING 15 0.0000
372 DRUG INEFFECTIVE 41 0.0000
373 DRUG INTOLERANCE 3 0.0000
374 HYPERHIDROSIS 4 0.0000
375 NIGHT SWEATS 1 0.0000
376 EYE DISORDER 1 0.0000
377 VISUAL ACUITY REDUCED 1 0.0000
378 URINARY RETENTION 1 0.0000
379 TYPE 2 DIABETES MELLITUS 1 0.0000
380 MYALGIA 5 0.0000
381 DELIRIUM 1 0.0000
382 INJURY 2 0.0000
383 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
384 PLATELET COUNT DECREASED 3 0.0000
385 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
386 CEREBRAL HAEMORRHAGE 1 0.0000
387 CRYING 1 0.0000
388 HYPERGLYCAEMIA 1 0.0000
389 RESPIRATORY FAILURE 2 0.0000
390 RESTLESSNESS 1 0.0000
391 DYSURIA 1 0.0000
392 THROMBOCYTOPENIA 3 0.0000
393 HEPATIC FUNCTION ABNORMAL 1 0.0000
394 DYSARTHRIA 1 0.0000
395 DYSPNOEA EXERTIONAL 1 0.0000
396 INTESTINAL OBSTRUCTION 1 0.0000
397 MUSCULAR WEAKNESS 3 0.0000
398 CHRONIC KIDNEY DISEASE 2 0.0000
399 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
400 COUGH 7 0.0000
401 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
402 PSORIATIC ARTHROPATHY 1 0.0000
403 DYSKINESIA 1 0.0000
404 BLINDNESS 1 0.0000
405 OSTEOPOROSIS 1 0.0000
406 DIZZINESS 12 0.0000
407 POLLAKIURIA 1 0.0000
408 HEADACHE 15 0.0000
409 RENAL FAILURE ACUTE 1 0.0000
410 MENTAL DISORDER 1 0.0000
411 DEHYDRATION 3 0.0000
412 PULMONARY OEDEMA 1 0.0000
413 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
414 GASTROINTESTINAL DISORDER 2 0.0000
415 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
416 THERAPY NON-RESPONDER 1 0.0000
417 NO ADVERSE EVENT 4 0.0000
418 SKIN DISCOLOURATION 1 0.0000
419 ADVERSE EVENT 2 0.0000
420 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
421 RENAL DISORDER 1 0.0000
422 BLOOD CHOLESTEROL INCREASED 1 0.0000
423 SWELLING 2 0.0000
424 PULMONARY EMBOLISM 2 0.0000
425 HYPOAESTHESIA 3 0.0000
426 SYNCOPE 2 0.0000
427 THERAPY CESSATION 1 0.0000
428 HAEMOGLOBIN DECREASED 2 0.0000
429 BRADYCARDIA 1 0.0000
430 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
431 INSOMNIA 5 0.0000
432 ASTHENIA 7 0.0000
433 OVERDOSE 4 0.0000
434 MALAISE 8 0.0000
435 PRURITUS 7 0.0000
436 HAEMATOCHEZIA 1 0.0000
437 ARTHROPATHY 1 0.0000
438 ABDOMINAL DISCOMFORT 3 0.0000
439 BLISTER 1 0.0000
440 HYPONATRAEMIA 1 0.0000
441 ANXIETY 5 0.0000
442 CONVULSION 1 0.0000
443 PRODUCT SUBSTITUTION ISSUE 1 0.0000
444 DECREASED APPETITE 4 0.0000
445 DYSPHONIA 1 0.0000
446 PALPITATIONS 2 0.0000
447 DISEASE PROGRESSION 2 0.0000
448 IRRITABILITY 1 0.0000
449 VERTIGO 1 0.0000
450 DISCOMFORT 1 0.0000
451 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
452 CHEST PAIN 3 0.0000
453 EXPOSURE DURING PREGNANCY 1 0.0000
454 RASH 7 0.0000
455 BLOOD GLUCOSE INCREASED 3 0.0000
456 ANAEMIA 3 0.0000
457 INTENTIONAL OVERDOSE 1 0.0000
458 AMNESIA 1 0.0000
459 SWELLING FACE 1 0.0000
460 INFUSION RELATED REACTION 1 0.0000
461 SOMNOLENCE 3 0.0000
462 BURNING SENSATION 1 0.0000
463 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
464 DIARRHOEA 9 0.0000
465 MOBILITY DECREASED 1 0.0000
466 BRONCHITIS 1 0.0000
467 DIABETES MELLITUS 1 0.0000
468 ARTHRITIS 1 0.0000
469 PARAESTHESIA 2 0.0000
470 PROSTATE CANCER 1 0.0000
471 CONFUSIONAL STATE 2 0.0000
472 DYSPNOEA 7 0.0000
473 DRY MOUTH 1 0.0000
474 TREMOR 2 0.0000
475 COMPLETED SUICIDE 1 0.0000
476 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
477 MUSCULOSKELETAL STIFFNESS 1 0.0000
478 NAUSEA 9 0.0000
479 TACHYCARDIA 1 0.0000
480 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
481 SUICIDAL IDEATION 1 0.0000
482 MUSCLE SPASMS 2 0.0000
483 OROPHARYNGEAL PAIN 1 0.0000
484 PRODUCT USE ISSUE 2 0.0000
485 NEUROPATHY PERIPHERAL 1 0.0000
486 MIGRAINE 1 0.0000
487 CONTUSION 1 0.0000
488 ALOPECIA 2 0.0000
489 HEART RATE INCREASED 1 0.0000
490 HYPOTENSION 2 0.0000
491 SINUSITIS 1 0.0000
492 HYPERTENSION 2 0.0000
493 CONSTIPATION 2 0.0000
494 FATIGUE 7 0.0000
495 WEIGHT INCREASED 2 0.0000
496 RHEUMATOID ARTHRITIS 1 0.0000
497 CHILLS 1 0.0000
498 JOINT SWELLING 1 0.0000
499 EMOTIONAL DISTRESS 1 0.0000
500 PAIN 5 0.0000
501 DEATH 7 0.0000
502 VISUAL IMPAIRMENT 1 0.0000
503 LOSS OF CONSCIOUSNESS 1 0.0000
504 DRY SKIN 1 0.0000
505 PRODUCT QUALITY ISSUE 1 0.0000
506 VISION BLURRED 1 0.0000
507 WEIGHT DECREASED 2 0.0000
508 PAIN IN EXTREMITY 2 0.0000
509 HOSPITALISATION 1 0.0000
510 DRUG DEPENDENCE 1 0.0000
511 URINARY TRACT INFECTION 1 0.0000
512 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
513 GAIT DISTURBANCE 1 0.0000
514 ERYTHEMA 1 0.0000
515 ARTHRALGIA 2 0.0000
516 DEPRESSION 1 0.0000
517 FEELING ABNORMAL 1 0.0000